Brazil advances development and production of multiple chikungunya vaccine candidates

Brazilian health authorities are evaluating a non-live virus vaccine while the Butantan Institute initiates domestic production of a separate candidate. Concurrently, researchers at the University of São Paulo are conducting preclinical animal trials on a third technology, signaling a multi-pronged effort to address rising regional transmission.